Cover Image
市場調查報告書

培養皮膚 (皮膚替代品) - 開發中產品分析

Tissue Engineered - Skin Substitutes - Pipeline Review, 2015

出版商 GlobalData 商品編碼 341958
出版日期 內容資訊 英文 67 Pages
訂單完成後即時交付
價格
Back to Top
培養皮膚 (皮膚替代品) - 開發中產品分析 Tissue Engineered - Skin Substitutes - Pipeline Review, 2015
出版日期: 2015年09月14日 內容資訊: 英文 67 Pages
簡介

本報告提供培養皮膚 (皮膚替代品) 的開發中產品調查分析,提供您主要開發中產品,主要企業,各開發階段的開發中產品,主要的臨床實驗資料,最近的趨勢等相關的系統性資訊。

第1章 目錄

第2章 簡介

  • 培養皮膚 (皮膚替代品) 概要

第3章 開發中的產品

  • 培養皮膚 (皮膚替代品) - 開發中產品:各開發階段
  • 培養皮膚 (皮膚替代品) - 開發中產品:各市場區隔
  • 培養皮膚 (皮膚替代品) - 開發中產品:各地區
  • 培養皮膚 (皮膚替代品) - 開發中產品:各法規途徑
  • 培養皮膚 (皮膚替代品) - 開發中產品:各審核時期 (預定)

第4章 培養皮膚 (皮膚替代品) :正在開發的開發中產品 (各企業)

  • 培養皮膚 (皮膚替代品) 企業 - 開發中產品:各開發階段
  • 培養皮膚 (皮膚替代品) - 開發中產品:各開發階段

第5章 培養皮膚 (皮膚替代品) 企業與產品概要

  • Adept Medical Limited
  • AGAM Biological Products
  • Agenta Biotechnologies, Inc.
  • Organogenesis, Inc.
  • Smith & Nephew Plc
  • Sree Chitra Tirunal Institute for Medical Sciences & Technology
  • Stratatech Corporation
  • Tel Aviv University
  • Tissue Regenix Ltd
  • Worcester Polytechnic Institute

第6章 培養皮膚 (皮膚替代品) :最近的趨勢

第7章 附錄

圖表

目錄
Product Code: GDME0069EPD

GlobalData's Medical Devices sector report, "Tissue Engineered - Skin Substitutes - Pipeline Review, 2015" provides an overview of Tissue Engineered - Skin Substitutes currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Tissue Engineered - Skin Substitutes pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Tissue Engineered - Skin Substitutes under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Tissue Engineered - Skin Substitutes and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Tissue Engineered - Skin Substitutes under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Tissue Engineered - Skin Substitutes Overview

3. Products under Development

  • 3.1. Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development
  • 3.2. Tissue Engineered - Skin Substitutes - Pipeline Products by Segment
  • 3.3. Tissue Engineered - Skin Substitutes - Pipeline Products by Territory
  • 3.4. Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path
  • 3.5. Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date

4. Tissue Engineered - Skin Substitutes - Pipeline Products under Development by Companies

  • 4.1. Tissue Engineered - Skin Substitutes Companies - Pipeline Products by Stage of Development
  • 4.2. Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development

5. Tissue Engineered - Skin Substitutes Companies and Product Overview

  • 5.1. Adept Medical Limited Company Overview
    • 5.1.1. Adept Medical Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. AGAM Biological Products Company Overview
    • 5.2.1. AGAM Biological Products Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Agenta Biotechnologies, Inc. Company Overview
    • 5.3.1. Agenta Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Organogenesis, Inc. Company Overview
    • 5.4.1. Organogenesis, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Smith & Nephew Plc Company Overview
    • 5.5.1. Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview
    • 5.6.1. Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. Stratatech Corporation Company Overview
    • 5.7.1. Stratatech Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. Tel Aviv University Company Overview
    • 5.8.1. Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Tissue Regenix Ltd Company Overview
    • 5.9.1. Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. Worcester Polytechnic Institute Company Overview
    • 5.10.1. Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview

6. Tissue Engineered - Skin Substitutes- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development
  • Table 2: Tissue Engineered - Skin Substitutes - Pipeline Products by Segment
  • Table 3: Tissue Engineered - Skin Substitutes - Pipeline Products by Territory
  • Table 4: Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path
  • Table 5: Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date
  • Table 6: Tissue Engineered - Skin Substitutes Companies - Pipeline Products by Stage of Development
  • Table 7: Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development
  • Table 8: Adept Medical Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 9: Plastic Surgery Graft - Product Status
  • Table 10: Plastic Surgery Graft - Product Description
  • Table 11: AGAM Biological Products Pipeline Products & Ongoing Clinical Trials Overview
  • Table 12: Skin Substitute - Product Status
  • Table 13: Skin Substitute - Product Description
  • Table 14: Agenta Biotechnologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 15: Implantable Mesh - Tissue Support - Product Status
  • Table 16: Implantable Mesh - Tissue Support - Product Description
  • Table 17: Skin Graft - Post-Burns - Product Status
  • Table 18: Skin Graft - Post-Burns - Product Description
  • Table 19: Organogenesis, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Dermagraft - Epidermolysis Bullosa - Product Status
  • Table 21: Dermagraft - Epidermolysis Bullosa - Product Description
  • Table 22: Dermagraft - Rotator Cuff Repair - Product Status
  • Table 23: Dermagraft - Rotator Cuff Repair - Product Description
  • Table 24: Dermagraft - Venous Leg Ulcers Repair - Product Status
  • Table 25: Dermagraft - Venous Leg Ulcers Repair - Product Description
  • Table 26: Smith & Nephew Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 27: ICX-SKN - Product Status
  • Table 28: ICX-SKN - Product Description
  • Table 29: KERAGRAF - Product Status
  • Table 30: KERAGRAF - Product Description
  • Table 31: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Skin Graft Substitutes - Wound - Product Status
  • Table 33: Skin Graft Substitutes - Wound - Product Description
  • Table 34: Stratatech Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: ExpressGraft - Antineoplastic - Product Status
  • Table 36: ExpressGraft - Antineoplastic - Product Description
  • Table 37: ExpressGraft - Sclerotic Digital Ulcers - Product Status
  • Table 38: ExpressGraft - Sclerotic Digital Ulcers - Product Description
  • Table 39: ExpressGraft Antimicrobial - Diabetic Foot Ulcers - Product Status
  • Table 40: ExpressGraft Antimicrobial - Diabetic Foot Ulcers - Product Description
  • Table 41: ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Status
  • Table 42: ExpressGraft Antimicrobial - Venous Leg Ulcers - Product Description
  • Table 43: ExpressGraft Pro-Angeogenic - Venous Leg Ulcers - Product Status
  • Table 44: ExpressGraft Pro-Angeogenic - Venous Leg Ulcers - Product Description
  • Table 45: ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Status
  • Table 46: ExpressGraft Pro-Angiogenic - Diabetic Foot Ulcers - Product Description
  • Table 47: ExpressGraftEnhance Tissue - Product Status
  • Table 48: ExpressGraftEnhance Tissue - Product Description
  • Table 49: StrataGraft - Epidermolysis Bullosa - Product Status
  • Table 50: StrataGraft - Epidermolysis Bullosa - Product Description
  • Table 51: StrataGraft - Scar Revision - Product Status
  • Table 52: StrataGraft - Scar Revision - Product Description
  • Table 53: StrataGraft - Scleroderma Digital Ulcers - Product Status
  • Table 54: StrataGraft - Scleroderma Digital Ulcers - Product Description
  • Table 55: StrataGraft - Severe Burns - Product Status
  • Table 56: StrataGraft - Severe Burns - Product Description
  • Table 57: Tel Aviv University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 58: Artificial Skin Graft - Product Status
  • Table 59: Artificial Skin Graft - Product Description
  • Table 60: Tissue Regenix Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 61: dCELL Dermis Matrix - Acute Wounds - Product Status
  • Table 62: dCELL Dermis Matrix - Acute Wounds - Product Description
  • Table 63: dCELL Human Dermis - Chronic Wounds - Product Status
  • Table 64: dCELL Human Dermis - Chronic Wounds - Product Description
  • Table 65: dCELL Human Dermis - Plastic Surgery - Product Status
  • Table 66: dCELL Human Dermis - Plastic Surgery - Product Description
  • Table 67: Worcester Polytechnic Institute Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: Extracellular Matrix Scaffold - Product Status
  • Table 69: Extracellular Matrix Scaffold - Product Description
  • Table 70: Glossary

List of Figures

  • Figure 1: Tissue Engineered - Skin Substitutes - Pipeline Products by Stage of Development
  • Figure 2: Tissue Engineered - Skin Substitutes - Pipeline Products by Segment
  • Figure 3: Tissue Engineered - Skin Substitutes - Pipeline Products by Territory
  • Figure 4: Tissue Engineered - Skin Substitutes - Pipeline Products by Regulatory Path
  • Figure 5: Tissue Engineered - Skin Substitutes - Pipeline Products by Estimated Approval Date
Back to Top